AzTrials
AzTrials

Psychological StressIHPIPO'TO'TSPNCT06878885

Trauma and Cardiometabolic Health in an American Indian Community

A study testing Acute psychological stress task (Paced Auditory Serial Addition Task) in people with Psychological Stress and Cardiometabolic Conditions, run by Montana State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Volunteers for the study are asked to participate in two laboratory sessions. In the first laboratory session, volunteers are asked to provide a blood sample which will be used to measure factors related to health. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
What is being tested?
Acute psychological stress task (Paced Auditory Serial Addition Task)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteUnited States
Study dates
10 May 2024to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-40 years
  • Identifying as American Indian
  • Living on or near Blackfeet reservation

Who cannot join

  • Uncontrolled hypertension

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Neha John-Henderson, PhD contact

(406) 994-6052

neha.johnhenderson@montana.edu

Annie Ginty, PhD contact

(254)710-2236

annie_ginty@baylor.edu

United States1 site, 1 recruiting
  • Blackfeet Community College

    Browning, Montana, 59417

    Betty Henderson-Matthews, MA, 406-338-5441 ext. 2800, b_mathews@bfcc.edu

    Betty Henderson-Matthews, MA

    Recruiting

Other trials in United States

About this study

Volunteers for the study are asked to participate in two laboratory sessions. In the first laboratory session, volunteers are asked to provide a blood sample which will be used to measure factors related to health. Participants also complete questionnaires related to demographic and health-related information and undergo evaluations of their body composition. In the second laboratory visit, participants are asked to have cardiovascular, neuroendocrine, and inflammatory activity measured during a brief period of rest and during a short challenging psychological task. Participants will also complete questionnaires. The study is designed to examine the associations between experiences such as trauma and resiliency with changes in bodily systems during a challenge and current health.

Read the detailed description

This cross-sectional study will examine the association between factors of resiliency and trauma with physiological (cardiovascular, neuroendocrine, inflammatory) responses to acute stress and current mental and physical health. Study volunteers will include individuals who identify as American Indian and currently live on and near the Blackfeet Reservation. Study volunteers will be asked to provide information that will be used to measure: correlates of cardiometabolic and mental health, acute psychological stress, arterial stiffness. Results of the study will help increase knowledge of cardiometabolic and mental health in the context of past and ongoing trauma and resiliency.

Being tested
Acute psychological stress task (Paced Auditory Serial Addition Task)
Medical subject headings
Stress, Psychological, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acute psychological stress task (Paced Auditory Serial Addition Task)Behavioural

    Volunteers will complete a 4-minute Paced Auditory Serial Addition Task which is a standardized laboratory challenge that is widely used to monitor cardiovascular, neuroendocrine, and inflammatory responses in the laboratory.

Study groups in NCT06878885
Study groupRoleWhat they receive
Paced Auditory Serial Addition TaskExperimentalVolunteers are presented with an audio playing of single digit numbers between 1 and 9. They are instructed to add the number with the number previously presented and say the answer out loud. Volunteers are told their performance is being scored by research assistants. Volunteers are also instructed to look at themselves in a mirror while partaking in the task. Volunteers are informed they can discontinue at any time. Volunteers complete brief questionnaires before and after the task to asses their perceptions of stress, arousal, and anxiety.
Receives: Behavioral: Acute psychological stress task (Paced Auditory Serial Addition Task)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in systolic blood pressure activity from baseline to task

    The mean systolic blood pressure (mmHg) will be subtracted from the mean of the task period.

    Measured: 10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

  2. Changes in diastolic blood pressure activity from baseline to task

    The mean diastolic blood pressure (mmHg) will be subtracted from the mean of the task period.

    Measured: 10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

  3. Changes in heart rate activity from baseline to task

    The mean heart rate (bpm) will be subtracted from the mean of the task period.

    Measured: 10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

  4. Change in cortisol from baseline to task

    Salivary samples will be taken to measure cortisol (nmol/L) the mean from the peak stress period will be subtracted from the baseline

    Measured: Baseline will be subtracted from the peak (15 minutes after task onset, 35 minute task onset)

  5. Changes in IL-6 from baseline to task

    IL-6 (pg/mL) measured at baseline will be subtracted from the IL-6 measured post task.

    Measured: Baseline will be subtracted from the level 30 minutes after task onset.

  6. Pulse wave velocity

    Pulse wave velocity in m/s will be assessed by dual impedance cardiography as a non-invasive indicator of arterial stiffness. This measure will be derived from the 5 minute baseline period.

    Measured: 5 minutes

  7. Resting systolic blood pressure

    Resting systolic blood pressure (mmHg)

    Measured: 10 minutes

  8. Resting diastolic blood pressure

    Resting diastolic blood pressure (mmHg)

    Measured: 10 minutes

  9. Inflammatory and anti-inflammatory cytokines

    Circulating levels of C-reactive protein, interleukin-6, tumor necrosis factor-a, monocyte chemoattractant protein-1, interleukin-1b, interleukin-10, and adiponectin will be assessed via a blood draw. A composite score will be created.

    Measured: 5 minutes

  10. Hemoglobin A1c

    Hemoglobin A1c (nmol/L) will be assessed via blood draw

    Measured: 5 minutes

  11. Glucose

    Glucose (nmol/L) will be assessed via blood draw

    Measured: 5 minutes

  12. Insulin

    Insulin (mL) will be assessed via blood draw

    Measured: 5 minutes

  13. Cholesterol

    Total cholesterol (mg) will be assessed via blood draw

    Measured: 5 minutes

  14. Low-density lipoprotein

    Low-density lipoprotein (mg/dL) will be assessed via blood draw

    Measured: 5 minutes

  15. High-density lipoprotein

    high-density lipoprotein (mg/dL) will be assessed via blood draw

    Measured: 5 minutes

  16. Triglycerides

    Triglycerides (mmol/L) will be assessed via blood draw

    Measured: 5 minutes

  17. Waist circumference

    Waist circumference

    Measured: 2 minutes

  18. Hip circumference

    Hip circumference

    Measured: 2 minutes

  19. Depressive symptomology (Hospital Anxiety Depression Questionnaire depression subscale)

    Hospital Anxiety Depression Questionnaire (depression subscale)

    Measured: 10 minutes

  20. Depressive symptomology (PHQ-9)

    PHQ-9

    Measured: 10 minutes

  21. Anxiety symptomtology

    Hospital Anxiety Depression Questionnaire (Anxiety subscale)

    Measured: 5 minutes

  22. Alcohol use

    Alcohol use will be assessed using the Alcohol Use Identification Test

    Measured: 10 minutes

  23. Substance use

    A cumulative score of substance use will be reported by indicating the number of recreational drugs "ever" tried

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2025
  2. Study start10 May 2024
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
The study is designed to examine cardiovascular, neuroendocrine, and inflammatory responses to a brief (4 minutes) mental arithmetic task (i.e., a psychological challenge) in the laboratory. Cardiovascular activity will be measured during a resting baseline period (10 minutes) and during the task (4 minutes). Participants will provide salivary samples before the task and after the task (\~20-90 minutes) which will be used to assess neuroendocrine (i.e., cortisol) and inflammatory (i.e., IL-6). Cardiovascular, neuroendocrine, and inflammatory responses will be examined in relation to other study outcomes.
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06878885
Sponsor's protocol ID
163237
Other IDs
5R01HL163237-02
Acronym
IHPIPO'TO'TSP
Status last verified
Mar 2025
First submitted
10 Jan 2025
Last updated
17 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Acute psychological stress task (Paced Auditory Serial Addition Task) in people with Psychological Stress and Cardiometabolic Conditions, run by Montana State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Neha John-Henderson, PhD ((406) 994-6052, neha.johnhenderson@montana.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in systolic blood pressure activity from baseline to task (time frame: 10 minute resting baseline mean will be subtracted from the 4 minute task period for each value). The study lists 23 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in